CGN Advisors LLC Boosts Stake in Gilead Sciences, Inc. (NASDAQ:GILD)

CGN Advisors LLC raised its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 15.3% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 31,585 shares of the biopharmaceutical company’s stock after buying an additional 4,187 shares during […]

Related Keywords

United States ,Canada ,America ,Merdad Parsey ,Complera Eviplera ,Andrewd Dickinson ,Investment Consulting Inc ,Gilead Sciences Profile ,Royal Bank ,Strategic Investment Solutions Inc ,News Ratings For Gilead Sciences Daily ,Gilead Sciences Dividend Announcement ,Gilead Sciences Inc ,Gilead Sciences Stock Down ,Venturi Wealth Management ,Cgn Advisors ,Gilead Sciences ,Heritage Wealth Management ,Nasdaq ,Insider Activity At Gilead Sciences ,Quarter For Gilead Sciences ,Cantor Fitzgerald ,Securities Exchange Commission ,Free Report ,Wealth Management ,Investment Solutions ,Sciences Stock Down ,Get Free Report ,Visit Holdingschannel ,Gilead Sciences Daily ,Nasdaq Gild ,Gild ,Medical ,37555810 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,